Mitotic catastrophe–related six-gene signature predicts prognosis, tumor immune landscape, and therapeutic response in lung adenocarcinoma
Abstract Background Lung adenocarcinoma (LUAD) exhibits significant molecular and immune heterogeneity, limiting the prognostic and therapeutic value of single biomarkers. Mitotic catastrophe (MC) is a key biological axis, but externally validated MC-related gene (MCRG) signatures integrating immune...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2026-05-01
|
| シリーズ: | BMC Medical Genomics |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1186/s12920-026-02380-z |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|